These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 29725729)
1. Large-scale identification and visualization of human liver N-glycome enriched from LO2 cells. Xiao K; Han Y; Tian Z Anal Bioanal Chem; 2018 Jul; 410(17):4195-4202. PubMed ID: 29725729 [TBL] [Abstract][Full Text] [Related]
2. Comparative Glycomics Study of Cell-Surface N-Glycomes of HepG2 versus LO2 Cell Lines. Han Y; Xiao K; Tian Z J Proteome Res; 2019 Jan; 18(1):372-379. PubMed ID: 30343578 [TBL] [Abstract][Full Text] [Related]
3. Large-scale identification and visualization of N-glycans with primary structures using GlySeeker. Xiao K; Wang Y; Shen Y; Han Y; Tian Z Rapid Commun Mass Spectrom; 2018 Jan; 32(2):142-148. PubMed ID: 29105226 [TBL] [Abstract][Full Text] [Related]
4. Large-Scale Identification and Fragmentation Pathways Analysis of N-Glycans from Mouse Brain. Shen Y; You Y; Xiao K; Chen Y; Tian Z J Am Soc Mass Spectrom; 2019 Jul; 30(7):1254-1261. PubMed ID: 31098956 [TBL] [Abstract][Full Text] [Related]
5. Large-scale glycomics for discovering cancer-associated N-glycans by integrating glycoblotting and mass spectrometry. Amano M; Nishimura S Methods Enzymol; 2010; 478():109-25. PubMed ID: 20816476 [TBL] [Abstract][Full Text] [Related]
6. Structures of disease-specific serum alpha-fetoprotein isoforms. Johnson PJ; Poon TC; Hjelm NM; Ho CS; Blake C; Ho SK Br J Cancer; 2000 Nov; 83(10):1330-7. PubMed ID: 11044358 [TBL] [Abstract][Full Text] [Related]
7. In-depth N-glycome profiling of paired colorectal cancer and non-tumorigenic tissues reveals cancer-, stage- and EGFR-specific protein N-glycosylation. Sethi MK; Kim H; Park CK; Baker MS; Paik YK; Packer NH; Hancock WS; Fanayan S; Thaysen-Andersen M Glycobiology; 2015 Oct; 25(10):1064-78. PubMed ID: 26085185 [TBL] [Abstract][Full Text] [Related]
8. Native Mass Spectrometry Meets Glycomics: Resolving Structural Detail and Occupancy of Glycans on Intact Glycoproteins. Chen S; Wu D; Robinson CV; Struwe WB Anal Chem; 2021 Aug; 93(30):10435-10443. PubMed ID: 34279906 [TBL] [Abstract][Full Text] [Related]
9. A comprehensive glycome profiling of Huntington's disease transgenic mice. Gizaw ST; Koda T; Amano M; Kamimura K; Ohashi T; Hinou H; Nishimura S Biochim Biophys Acta; 2015 Sep; 1850(9):1704-18. PubMed ID: 25907331 [TBL] [Abstract][Full Text] [Related]
10. A pilot study of salivary N-glycome in HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Qin Y; Zhong Y; Ma T; Zhang J; Yang G; Guan F; Li Z; Li B Glycoconj J; 2017 Aug; 34(4):523-535. PubMed ID: 28389847 [TBL] [Abstract][Full Text] [Related]
11. Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour. Johnson PJ; Poon TC; Hjelm NM; Ho CS; Ho SK; Welby C; Stevenson D; Patel T; Parekh R; Townsend RR Br J Cancer; 1999 Dec; 81(7):1188-95. PubMed ID: 10584881 [TBL] [Abstract][Full Text] [Related]
12. Glycoblotting method allows for rapid and efficient glycome profiling of human Alzheimer's disease brain, serum and cerebrospinal fluid towards potential biomarker discovery. Gizaw ST; Ohashi T; Tanaka M; Hinou H; Nishimura S Biochim Biophys Acta; 2016 Aug; 1860(8):1716-27. PubMed ID: 26968461 [TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of total serum glycome in human and mouse. Yoshida Y; Furukawa JI; Naito S; Higashino K; Numata Y; Shinohara Y Proteomics; 2016 Nov; 16(21):2747-2758. PubMed ID: 27601404 [TBL] [Abstract][Full Text] [Related]
14. Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis. Kamiyama T; Yokoo H; Furukawa J; Kurogochi M; Togashi T; Miura N; Nakanishi K; Kamachi H; Kakisaka T; Tsuruga Y; Fujiyoshi M; Taketomi A; Nishimura S; Todo S Hepatology; 2013 Jun; 57(6):2314-25. PubMed ID: 23322672 [TBL] [Abstract][Full Text] [Related]
15. Protein glycosylation in viral hepatitis-related HCC: Characterization of heterogeneity, biological roles, and clinical implications. Zhang S; Cao X; Gao Q; Liu Y Cancer Lett; 2017 Oct; 406():64-70. PubMed ID: 28789967 [TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of site-specific N-glycans on sera haptoglobin β chain in liver diseases. Zhang S; Jiang K; Sun C; Lu H; Liu Y Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):1021-9. PubMed ID: 24103369 [TBL] [Abstract][Full Text] [Related]
17. GP73 N-glycosylation at Asn144 reduces hepatocellular carcinoma cell motility and invasiveness. Jiang K; Li W; Zhang Q; Yan G; Guo K; Zhang S; Liu Y Oncotarget; 2016 Apr; 7(17):23530-41. PubMed ID: 26993603 [TBL] [Abstract][Full Text] [Related]
18. Analysis of fucosylation in liver-secreted N-glycoproteins from human hepatocellular carcinoma plasma using liquid chromatography with tandem mass spectrometry. Ji ES; Hwang H; Park GW; Lee JY; Lee HK; Choi NY; Jeong HK; Kim KH; Kim JY; Lee S; Ahn YH; Yoo JS Anal Bioanal Chem; 2016 Nov; 408(27):7761-7774. PubMed ID: 27565792 [TBL] [Abstract][Full Text] [Related]
19. Identifying N-Glycan Biomarkers in Colorectal Cancer by Mass Spectrometry. Sethi MK; Hancock WS; Fanayan S Acc Chem Res; 2016 Oct; 49(10):2099-2106. PubMed ID: 27653471 [TBL] [Abstract][Full Text] [Related]
20. Relative versus absolute quantitation in disease glycomics. Moh ES; Thaysen-Andersen M; Packer NH Proteomics Clin Appl; 2015 Apr; 9(3-4):368-82. PubMed ID: 25684231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]